LIMINATUS PHARMA, INC. (LIMNW) Operating cash flow 2024–2025
LIMINATUS PHARMA, INC. (LIMNW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.0MFY2025 · since FY2024: -$1.5M → -$10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.0M | -586.6% |
| FY2024 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LIMNW financial trends
LIMNW RevenueLIMNW Net incomeLIMNW Net marginLIMNW Gross profitLIMNW Gross marginLIMNW Operating incomeLIMNW Operating marginLIMNW Free cash flowLIMNW Capital expendituresLIMNW Return on equityLIMNW Stock buybacksLIMNW Dividends paidLIMNW Total assetsLIMNW Total liabilitiesLIMNW Shareholders’ equityLIMNW overview →